{
    "msg": "获取章节试题成功",
    "data": {
        "test": {
            "ReturnMessage": "取数据成功",
            "APPEName": "ZY_LCZY_YTMJ",
            "GenDate": "Tue May 14 2019 23:15:44 GMT+0800 (CST)",
            "StyleItems": [
                {
                    "StyleID": 1,
                    "Style": "A1型题",
                    "Explain": "A1型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 14,
                    "TestItems": [
                        {
                            "Title": "f699ee7d492f5ec4b0ccce7e929c7c331eb48526221a52679d392eab20c12ec6",
                            "Explain": "钙拮抗药的药理作用包括：①对心脏的作用，负性肌力、负性频率和负性传导作用，故选项A所述错误；②对平滑肌作用，舒张血管，降低血压；③对红细胞、血小板的作用，降低血小板内钙浓度，使血小板释放功能障碍，血小板聚集受阻，同时增加红细胞的变形能力，降低血液黏滞度，故B、C所述错误；④抗动脉粥样硬化作用，故D所述正确。对胰岛素的分泌无影响，E不符合题意。故选D。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "房室结传导加快"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "增加血液黏滞度"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "促进血小板聚集"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "抗动脉粥样硬化"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "增加胰岛素分泌"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 35000560,
                            "ATestID": 35000560,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "4033f64beac783f4dd504c20c741b75f5315e93ab51f7c1b83ce0b7feb36d54bfcc5403e441afd80ef71253992f92f2ad689608c3f5cf709bbb4ed2ef1835350e5cbd2dae31f7ce6",
                            "Explain": "尼莫地平、氟桂利嗪等对短暂脑缺血发作、脑血栓形成等有效。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "C",
                                    "Content": "地尔硫[caozhuo.gif]"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "普尼拉明"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "尼莫地平"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43000514,
                            "ATestID": 43000514,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8c1d7af60f8c38387c158771f123de1c1e1a8373013e24b9e6929df69c41c53bab60f2640c2a9d176c53c17e189a2479594f2c5ee93a9b27fbb2fc8c9b946d9b4b1ef79784b01233",
                            "Explain": "维拉帕米属Ⅳ类抗心律失常药，为一种钙离子内流的抑制剂（慢通道阻滞剂）。在心脏，钙离子内流受抑制使窦房结和房室结的自律性降低，传导减慢，但很少影响心房、心室减低，影响收缩蛋白的活动，心肌收缩减弱，心脏做功减少，心肌氧耗减少。对血管，钙离子内流动脉压下降，心室后负荷降低。",
                            "TestPoint": "抗高血压药",
                            "Answer": "E",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "尼莫地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "尼群地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "D",
                                    "Content": "地尔硫[zhuo.gif]"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "维拉帕米"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002670,
                            "ATestID": 43002670,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "e34713f6697359fec51e09f4b3732e2756445ef9793b1dc38f68d04b328fc4fd653048614beab5e1a7b0c897ca3f7b66eefefa9a272809aa",
                            "Explain": "氨氯地平口服后6～12h后血药浓度达峰值，血清半衰期为35～50h，硝苯地平经10分钟生效，1?2小时达最大效应，作用维持6?7小时。尼卡地平口服后30min生效，1h血药浓度达高峰，最大效应30min至1.5h，维持3h，血浆半衰期约5h。尼索地平口服速释剂治疗心绞痛的最大效应时间为3h，治疗高血压为1～3h。降压效应与血药浓度有关。达峰时间为1～1.5h。尼群地平口服吸收良好，达90%以上。食物能增加尼群地平的吸收。血浆蛋白结合率大于90%。分布容积（Vd）为6L/kg。口服后30min收缩压开始下降，60min舒张压开始下降，降压作用在口服后1～2h最大，持续6～8h。",
                            "TestPoint": "抗高血压药",
                            "Answer": "C",
                            "Difficulty": "很难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "尼卡地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "氨氯地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "尼索地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "尼群地平"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002671,
                            "ATestID": 43002671,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "42ae35a16b6ced2e0d651f857daef3b8c6e996b57855fa4ef1033e55d6a5852f7ace7dcea742591bb708a68db1d17f72",
                            "Explain": "静注适用于治疗快速性室上性心律失常，使阵发性室上性心动过速转为窦性，使心房扑动或心房颤动的心室率减慢。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "D",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "房室传导阻滞"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "室性心动过速"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "室性期前收缩"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "阵发性室上性心动过速"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "强心苷过量的心律失常"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002672,
                            "ATestID": 43002672,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "cbc6e2bafeee287e37c69ea81286ff07351d13e94904559cf2e27c03d93f43d97394c7d1c9dc7e10",
                            "Explain": "维拉帕米静注适用于治疗快速性室上性心律失常，使阵发性室上性心动过速转为窦性，使心房扑动或心房颤动的心室率减慢。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "A",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "尼卡地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "尼索地平"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "E",
                                    "Content": "地尔硫[zhuo.gif]"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002673,
                            "ATestID": 43002673,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c6c53a7ae2bfc6e3d6d73f98917011b1d0effc39920794597619bb6e3af5e6c136791cc5e1da878a1bbff2249c143fb854d327f1792861cc",
                            "Explain": "钙通道蛋白由α1，α2，β，γ，δ等亚单位构成，其中α1是主要亚单位，是决定钙通道电压依赖性和药物敏感性的重要部分。各亚单位又可分出不同亚型，其中α1S，α1C，α1D构成L型钙通道。L型钙通道属电压依赖型钙通道，通道的开关主要取决于膜电位的变化，属长时程钙通道。其激活较慢激活电压相对较高，维持时间较长，主要分布在心肌细胞上。",
                            "TestPoint": "抗高血压药",
                            "Answer": "A",
                            "Difficulty": "很难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "α[1.gif]"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "B",
                                    "Content": "α[2.gif]"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "β"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "γ"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "8"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002674,
                            "ATestID": 43002674,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "086bb5cf998bb0db966235ecbae7f9eb6d4d02092fe0f8f1cbb29a6c6f1c747fd5c0ba5b40232ae7",
                            "Explain": "硝苯地平具有抑制Ca[~2+.gif]内流作用，能松弛血管平滑肌，扩张冠状动脉，增加冠脉血流量，提高心肌对缺血的耐受性，同时能扩张周围小动脉，降低外周血管阻力，从而使血压下降。小剂量扩张冠状动脉时并不影响血压，为较好的抗心绞痛药。",
                            "TestPoint": "抗高血压药",
                            "Answer": "D",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "氟桂嗪"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "普尼拉明"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "哌克昔林"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "桂利嗪"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002676,
                            "ATestID": 43002676,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "59bb26ecf37f4df56f714fc0ad437b906b8c710f837c8b67ba16201334b56d91d1f4aee0c34dda86b41263c1841cfb02",
                            "Explain": "口服用于治疗房性早搏或预防室上性心动过速发作。也用于治疗轻、中度高血压、肥厚性心肌病、口吃、食管痉挛和食管失弛缓症等。静脉推注用于中止阵发性室上性心动过速发作、房颤伴快速室率，也用于中止触发活动引起的极短联律或特发性尖端扭转型室性心动过速。该品对中止阵发性室上性心动过速奏效迅速，效果显著，为治疗室上性心动过速的首选药物。下列情况应禁用：①心源性休克；②充血性心力衰竭，除非继发于室上性心动过速而对该品有效者；③Ⅱ至Ⅲ度房室传导阻滞；④重度低血压，收缩压<12kPa（90mmHg）；⑤病态窦房结综合征，除非已有人工心脏起搏；⑥预激或L-G-L综合征伴房颤或房扑，除非有人工心脏起搏。下列情况应慎用：①极度心动过缓；②心力衰竭，给该品前须先用洋地黄及利尿剂控制心力衰竭，中或重度心力衰竭[即肺楔嵌压>2.67kPa（20mmHg），喷血分数<20%]给该品可使病情恶化；③肝功能损害；④轻度至中度低血压，该品的周围血管扩张作用加重低血压；⑤肾功能损害。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "E",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "可用于治疗心绞痛"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "可用于治疗高血压"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "可用于治疗阵发性室上性心动过速"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "禁用于有传导阻滞的病人"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "禁用于心房颤动的病人"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002677,
                            "ATestID": 43002677,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0bf0db2ec76acb6c8038c4dc1315cf1b095c74ca760a078b069401f01d719d0f794733d726baab37",
                            "Explain": "硝苯地平，用于预防和治疗冠心病心绞痛，特别是变异型心绞痛和冠状动脉痉挛所致心绞痛。对呼吸功能没有不良影响，故适用于患有呼吸道阻塞性疾病的心绞痛患者，其疗效优于β受体拮抗剂。还适用于各种类型的高血压，对顽固性、重度高血压也有较好疗效。由于能降低后负荷，对顽固性充血性心力衰竭亦有良好疗效，宜于长期服用。对心率失常没有作用。",
                            "TestPoint": "抗高血压药",
                            "Answer": "D",
                            "Difficulty": "易",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "是二氢吡啶类钙离子通道阻断药"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "口服吸收迅速而完全"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "主要的不良反应是低血压"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "可用于治疗心律失常"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "可用于治疗高血压和心绞痛"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002678,
                            "ATestID": 43002678,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "59bb26ecf37f4df56f714fc0ad437b906c3ff5fc10db5d84a2c25421137ab384f4f9308ca4ece93d",
                            "Explain": "口服用于治疗房性早搏或预防室上性心动过速发作。也用于治疗轻、中度高血压、肥厚性心肌病、口吃、食管痉挛和食管失弛缓症等。静脉推注用于中止阵发性室上性心动过速发作、房颤伴快速室率，也用于中止触发活动引起的极短联律或特发性尖端扭转型室性心动过速。该品对中止阵发性室上性心动过速奏效迅速，效果显著，为治疗室上性心动过速的首选药物。对肥厚性心肌病有一定效果。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "B",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "Content": "是治疗阵发性室上性心动过速的首选药",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "对肥厚性心肌病无效",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "能改善心室的舒张功能",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "禁用于严重心衰的病人",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "能增加缺血心肌的冠脉流量",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002679,
                            "ATestID": 43002679,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "222375300d10e5ff548fb3db9bbfbabbdfd2ac56a11edbb034085f12732c4f4fed99271ddd2b305616f3d4014d0c6587f2e26c50ed37e0a4",
                            "Explain": "钙通道阻滞药根据其化学结构和对通道的选择性可以分为两类：（1）选择性钙通道阻滞剂，包括：①苯烷胺类，代表药有维拉帕米、加洛帕米等；②二氢吡啶类，代表药有硝苯地平、氨氯地平等；③苯硫[caozhuo.gif]类，代表药有地尔硫[caozhuo.gif]等 。（2）非选择性钙通道阻滞药，包括：①二苯哌嗪类，代表药有桂利嗪、氟桂利嗪；②普尼拉明类，代表药有普尼拉明等；③其他类，如派克昔林等 。故选B",
                            "TestPoint": "钙拮抗药",
                            "Answer": "B",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "维拉帕米（异搏定）"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "氟桂利嗪"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "哌克昔林"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "钙片"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015434,
                            "ATestID": 43015434,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0dea991b782beaa7cedada71d155b9c4941808a691850fc4da214176e45dbfdc1355ee512ce4cb9f2c0c1c7d8df01541df8f2191f7259055",
                            "Explain": "非二氢吡啶类包括维拉帕米等，对心脏和血管均有作用。本类药用药相对比较安全。一般不良反应有：颜面潮红、头痛、眩晕、恶心、便秘等。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "维拉帕米（异搏定）"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "氯沙坦"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "利多卡因"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015437,
                            "ATestID": 43015437,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "700f6b70d2ab7f41dec29550bb4999d4f3642d8ba46c4bf782f548edc3130d7fa9587a9e920efd7e324791947ea8ca8cef6e0643ea50e75a",
                            "Explain": "二氢吡啶类钙拮抗剂包括：硝苯地平、尼卡地平、尼群地平、氨氯地平、尼莫地平等，维拉帕米属于苯烷胺类。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "氨氯地平"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "非洛地平"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "吲达帕胺"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "维拉帕米"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015438,
                            "ATestID": 43015438,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 5,
                    "Style": "A1/A2型题",
                    "Explain": "A1/A2型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 1,
                    "TestItems": [
                        {
                            "Title": "b3cdea88e4ca290dec04407217c38c0a64753d6393b4ad2d6e44ece930b906f50215c10f7d949769195205038320cc9c3c8aebb10397a8d0",
                            "Explain": "钙拮抗药阻滞Ca[SB2jia.gif]的内流，能明显舒张血管，主要舒张动脉，对静脉影响较小。动脉中又以冠状血管较为敏感，能舒张血管，增加冠脉流量及侧支循环量，有效治疗心绞痛。尼莫地平和氟桂利嗪舒张脑血管作用较强，能增加脑血流量。故选C。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "尼莫地平"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "D",
                                    "Content": "地尔硫[zhuo.gif]"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "戈洛帕米"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 41000527,
                            "ATestID": 41000527,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 2,
                    "Style": "A2型题",
                    "Explain": "A2型题：每一道考题是以一个小案例出现的，其下面都有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 1,
                    "TestItems": [
                        {
                            "Title": "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",
                            "Explain": "维拉帕米可能导致心动过缓（50次/分以下），偶尔发展成Ⅱ或Ⅲ度房室传导阻滞及心脏停搏；可能使预激或L-G-L综合征伴心房颤动或心房扑动者旁路传导加速，以致心率增快；心力衰竭；低血压；下肢水肿。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "C",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "硝酸甘油"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "硝酸异山梨酯"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "美托洛尔"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002680,
                            "ATestID": 43002680,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 3,
                    "Style": "B1型题",
                    "Explain": "B1型题：以下提供若干组考题，每组考题共用在考题前列出的A、B、C、D、E五个备选答案。请从中选择一个与问题关系最密切的答案。某个备选答案可能被选择一次、多次或不被选择。",
                    "Score": 1,
                    "Type": "BTEST",
                    "SubType": "单项",
                    "TestCount": 4,
                    "TestItems": [
                        {
                            "Title": "086bb5cf998bb0dbc0572d8a502187a0934a0a78172b1f9a1542f37beac01ee7a23c43f3dec7f9d1",
                            "Explain": "尼莫地平、尼卡地平、桂利嗪、氟桂利嗪等钙抗剂对脑血管有较强的选择性舒张作用，增加脑血流量，改善脑缺血后神经功能障碍症状 。临床上用于治疗脑血管痉挛和脑供血不足等疾病 。",
                            "TestPoint": "作用于血液及造血器官的药物",
                            "Answer": "A",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "氟桂嗪"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "地尔硫[zhuo.gif]"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "氨氯地平"
                                }
                            ],
                            "AllTestID": 43002681,
                            "BTestID": 43000683,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 320,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000683,
                                    "Title": "086bb5cf998bb0dbc0572d8a502187a0934a0a78172b1f9a1542f37beac01ee7a23c43f3dec7f9d1",
                                    "Explain": "尼莫地平、尼卡地平、桂利嗪、氟桂利嗪等钙抗剂对脑血管有较强的选择性舒张作用，增加脑血流量，改善脑缺血后神经功能障碍症状 。临床上用于治疗脑血管痉挛和脑供血不足等疾病 。",
                                    "TestPoint": "作用于血液及造血器官的药物",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000684,
                                    "Title": "ae119ad1c3865370a2d9c96ada649597682831d39f484a9912c204fbd8e7c1ab",
                                    "Explain": "t[1-2.gif]最长的药物是氨氯地平。",
                                    "TestPoint": "作用于血液及造血器官的药物",
                                    "Answer": "E",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000685,
                                    "Title": "f5ac51c443f5fa3604721b3bb6521a684e5540f96449253bd226f4a5f8b83f6f33202fb820d12ec75c9c326c90cac3a66a29134ca47f82c700600d3b23ec0577",
                                    "Explain": "易引起反射性交感神经兴奋、心率加快的药物是硝苯地平。",
                                    "TestPoint": "抗高血压药",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000686,
                                    "Title": "f04f8c01679a7fc40c33a879ed3094b74403bf55cbc2eeb4a4f6fdc8fda4567cb329c4ee7b24b66e4a1f342295e78507",
                                    "Explain": "非选择性的钙离子通道阻断药是氟桂嗪。",
                                    "TestPoint": "作用于血液及造血器官的药物",
                                    "Answer": "A",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        }
                    ]
                }
            ]
        },
        "isVip": 0,
        "testInfo": [
            {
                "AllTestID": 35000560,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 35000560,
                        "ChildTableID": -1,
                        "UserCount": 2029,
                        "RightCount": 1317,
                        "FavCount": 46,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 22
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 35000560,
                    "ChildTableID": -1
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 22
            },
            {
                "AllTestID": 43000514,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43000514,
                        "ChildTableID": -1,
                        "UserCount": 1978,
                        "RightCount": 1484,
                        "FavCount": 41,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 13
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43000514,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 13
            },
            {
                "AllTestID": 43002670,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002670,
                        "ChildTableID": -1,
                        "UserCount": 2080,
                        "RightCount": 1102,
                        "FavCount": 62,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002670,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 43002671,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002671,
                        "ChildTableID": -1,
                        "UserCount": 2050,
                        "RightCount": 1088,
                        "FavCount": 66,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 39
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002671,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 39
            },
            {
                "AllTestID": 43002672,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002672,
                        "ChildTableID": -1,
                        "UserCount": 1919,
                        "RightCount": 1411,
                        "FavCount": 43,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 14
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002672,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 14
            },
            {
                "AllTestID": 43002673,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002673,
                        "ChildTableID": -1,
                        "UserCount": 1709,
                        "RightCount": 1645,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002673,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002674,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002674,
                        "ChildTableID": -1,
                        "UserCount": 1909,
                        "RightCount": 966,
                        "FavCount": 58,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 33
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002674,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 33
            },
            {
                "AllTestID": 43002676,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002676,
                        "ChildTableID": -1,
                        "UserCount": 1812,
                        "RightCount": 1356,
                        "FavCount": 42,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 18
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002676,
                    "ChildTableID": -1
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 18
            },
            {
                "AllTestID": 43002677,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002677,
                        "ChildTableID": -1,
                        "UserCount": 1955,
                        "RightCount": 1158,
                        "FavCount": 55,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002677,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 43002678,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002678,
                        "ChildTableID": -1,
                        "UserCount": 1923,
                        "RightCount": 1071,
                        "FavCount": 55,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 17
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002678,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 17
            },
            {
                "AllTestID": 43002679,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002679,
                        "ChildTableID": -1,
                        "UserCount": 1865,
                        "RightCount": 1005,
                        "FavCount": 52,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 18
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002679,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 18
            },
            {
                "AllTestID": 43015434,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015434,
                        "ChildTableID": -1,
                        "UserCount": 1716,
                        "RightCount": 1074,
                        "FavCount": 39,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 17
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015434,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 17
            },
            {
                "AllTestID": 43015437,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015437,
                        "ChildTableID": -1,
                        "UserCount": 1763,
                        "RightCount": 975,
                        "FavCount": 56,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 21
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015437,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 21
            },
            {
                "AllTestID": 43015438,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015438,
                        "ChildTableID": -1,
                        "UserCount": 1715,
                        "RightCount": 1223,
                        "FavCount": 27,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015438,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 41000527,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000527,
                        "ChildTableID": -1,
                        "UserCount": 1669,
                        "RightCount": 1355,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 10
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000527,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 10
            },
            {
                "AllTestID": 43002680,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002680,
                        "ChildTableID": -1,
                        "UserCount": 1784,
                        "RightCount": 1134,
                        "FavCount": 57,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002680,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 43002681,
                "ChildTableID": 43000683,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002681,
                        "ChildTableID": 43000683,
                        "UserCount": 1803,
                        "RightCount": 1117,
                        "FavCount": 40,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002681,
                    "ChildTableID": 43000683
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43002681,
                "ChildTableID": 43000684,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002681,
                        "ChildTableID": 43000684,
                        "UserCount": 1730,
                        "RightCount": 1209,
                        "FavCount": 24,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 14
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002681,
                    "ChildTableID": 43000684
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 14
            },
            {
                "AllTestID": 43002681,
                "ChildTableID": 43000685,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002681,
                        "ChildTableID": 43000685,
                        "UserCount": 1799,
                        "RightCount": 1038,
                        "FavCount": 52,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002681,
                    "ChildTableID": 43000685
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 43002681,
                "ChildTableID": 43000686,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002681,
                        "ChildTableID": 43000686,
                        "UserCount": 1885,
                        "RightCount": 883,
                        "FavCount": 40,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002681,
                    "ChildTableID": 43000686
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            }
        ],
        "info": [],
        "encoded": 1,
        "examHistoryID": 0,
        "yimoinfo": [],
        "UserTime": 0
    },
    "status": 200
}